Rankings
▼
Calendar
LUNG Q2 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q2 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$12M
+232.2% YoY
Gross Profit
$9M
74.0% margin
Operating Income
-$13M
-103.9% margin
Net Income
-$13M
-106.2% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
+32.0%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$249M
Total Liabilities
$39M
Stockholders' Equity
$210M
Cash & Equivalents
$199M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$4M
+232.2%
Gross Profit
$9M
$1M
+792.2%
Operating Income
-$13M
-$12M
-10.0%
Net Income
-$13M
-$12M
-8.8%
Geographic Segments
UNITED STATES
$7M
54%
EMEA
$5M
39%
Asia Pacific
$875,000
7%
Other International Geographical Areas
$12,000
0%
← FY 2021
All Quarters
Q3 2021 →